Nestmedic S.A., together with its subsidiaries, engages in the manufacture, distribution, and sale of mobile telemedical solution under the Pregnabit brand. The company offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. It also provides Pregnabit Cloud, a software as a service system designed to work with telemedical cardiotocography examination devices implementing the required communication protocol to send measurement data during an examination; and PregnaView, a component of the Pregnabit system that functions as a separate medical device. The company sells its products through a distribution network and resellers worldwide. Nestmedic S.A. was incorporated in 2017 and is headquartered in Warsaw, Poland.